A Promising Heart Drug Failed. What Went So Wrong?

A clinical trial of a cardiac medication did not meet its primary endpoint of reducing heart attack incidence, according to trial results. The drug's mechanism showed promise in earlier testing phases. Cardiologists and the drug manufacturer are reviewing trial data to determine why the treatment did not demonstrate efficacy in the larger patient population studied.

Next story